Brain organoids are new tool for drug screening of neurological diseases
At the level of in vitro drug screening, the development of a phenotypic analysis system with high-content screening at the core provides a strong platform to support high-throughput drug screening. There are few systematic reports on brain organoids, as a new three-dimensional in vitro model, in te...
Main Authors: | Jin-Qi Zhou, Ling-Hui Zeng, Chen-Tao Li, Da-Hong He, Hao-Duo Zhao, Yan-Nan Xu, Zi-Tian Jin, Chong Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1884;epage=1889;aulast=Zhou |
Similar Items
-
Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue
by: Haowen Qiao, et al.
Published: (2022-05-01) -
Toward brain organoid-based precision medicine in neurodegenerative diseases
by: Jong-Chan Park, et al.
Published: (2022-10-01) -
Organoids in high-throughput and high-content screenings
by: Franziska L. Lampart, et al.
Published: (2023-03-01) -
Gene expression in organoids: an expanding horizon
by: Artem Smirnov, et al.
Published: (2023-03-01) -
Pancreatic islet organoids-on-a-chip: how far have we gone?
by: Jiaxiang Yin, et al.
Published: (2022-06-01)